当前位置: 首页 > 详情页

The Putative Tumor Suppressor miR-524-5p Directly Targets Jagged-1 and Hes-1 in Glioma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp,Lab Neurooncol, Tianjin 300052, Peoples R China; [2]Minist Educ, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300052, Peoples R China; [3]Tianjin Municipal Govt, Tianjin 300052, Peoples R China; [4]Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Peoples R China; [5]Capital Med Univ, Dept Neurosurg, Tiantan Hosp, Beijing 100050, Peoples R China; [6]Tianjin Neurol Inst, Neuropathol Lab, Tianjin 300052, Peoples R China; [7]Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China; [8]Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China
出处:
ISSN:

摘要:
Notch pathway plays critical role in stem cell maintenance and angiogenesis, as well as cell fate decisions of cancer. However, concrete mechanisms of notch pathway regulation in glioma were not well known, especially mediated by microRNAs. In this study, we identified a brain-specific miRNA, miR-524-5p, which was associated with the pathological grade and overall survival of gliomas. Restorated expression of miR-524-5p in glioma suppressed cell proliferation and invasion both in vitro and in vivo. Using bioinformatics and biological approaches, we found that Jagged-1 and Hes-1, two key components of notch pathway, were direct targets of miR-524-5p. Knocking down of Jagged-1 or Hes-1 partially phenocopied miR-524-5p re-expression, whereas forced expression of Jagged-1 or Hes-1 reversed the effects of miR-524-5p on proliferation and invasion of glioma. Moreover, miR-524-5p levels in glioma samples were inversely correlated with Jagged-1 and Hes-1 and their overexpressions were associated with poor survival. Thus, we have identified that miR-524-5p behaves as a tumor suppressor by negatively targeting Jagged-1 and Hes-1 and provides an additional option to inhibit this oncogene in gliomas.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2010]版:
Q1 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp,Lab Neurooncol, Tianjin 300052, Peoples R China; [2]Minist Educ, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300052, Peoples R China; [3]Tianjin Municipal Govt, Tianjin 300052, Peoples R China; [4]Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Peoples R China;
通讯作者:
通讯机构: [5]Capital Med Univ, Dept Neurosurg, Tiantan Hosp, Beijing 100050, Peoples R China; [8]Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院